Literature DB >> 25218000

Prognostic factors and oncologic outcomes of 56 salivary duct carcinoma patients in a single institution: high rate of systemic failure warrants targeted therapy.

Jong-Lyel Roh1, Jong-Ik Lee1, Seung-Ho Choi1, Soon Yuhl Nam1, Seon-Ok Kim2, Kyung-Ja Cho3, Sung-Bae Kim4, Sang Yoon Kim5.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25218000     DOI: 10.1016/j.oraloncology.2014.08.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  14 in total

1.  Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.

Authors:  Marlen Haderlein; Claudia Scherl; Sabine Semrau; Sebastian Lettmaier; Markus Hecht; Ramona Erber; Heinrich Iro; Rainer Fietkau; Abbas Agaimy
Journal:  Strahlenther Onkol       Date:  2017-08-21       Impact factor: 3.621

2.  A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.

Authors:  Mark R Gilbert; Arun Sharma; Nicole C Schmitt; Jonas T Johnson; Robert L Ferris; Umamaheswar Duvvuri; Seungwon Kim
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-05-01       Impact factor: 6.223

Review 3.  Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.

Authors:  Nicole C Schmitt; Hyunseok Kang; Arun Sharma
Journal:  Oral Oncol       Date:  2017-09-21       Impact factor: 5.337

4.  VDR in salivary gland homeostasis and cancer.

Authors:  Kara A DeSantis; Samantha L Robilotto; Mark Matson; Noor M Kotb; Cathryn M Lapierre; Zenab Minhas; Alana A Leder; Khushbakht Abdul; Emily M Facteau; JoEllen Welsh
Journal:  J Steroid Biochem Mol Biol       Date:  2020-01-17       Impact factor: 4.292

5.  Utilization of Nivolumab in Adenoid Cystic Carcinoma After Progression on Platinum-Based Chemotherapy.

Authors:  Diana V Maslov; Katharine Thomas; Marc Matrana
Journal:  Perm J       Date:  2021-05

6.  Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.

Authors:  Daisuke Kawakita; Yuichiro Tada; Yorihisa Imanishi; Shintaro Beppu; Kiyoaki Tsukahara; Satoshi Kano; Hiroyuki Ozawa; Kenji Okami; Yuichiro Sato; Akira Shimizu; Yukiko Sato; Chihiro Fushimi; Soichiro Takase; Takuro Okada; Hiroki Sato; Kuninori Otsuka; Yoshihiro Watanabe; Akihiro Sakai; Koji Ebisumoto; Takafumi Togashi; Yushi Ueki; Hisayuki Ota; Tomotaka Shimura; Toyoyuki Hanazawa; Shingo Murakami; Toshitaka Nagao
Journal:  Oncotarget       Date:  2017-01-03

7.  A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.

Authors:  Eline Boon; Miranda Bel; Wim van Boxtel; Winette T A van der Graaf; Robert J J van Es; Simone E J Eerenstein; Robert J Baatenburg de Jong; Michiel W M van den Brekel; Lilly-Ann van der Velden; Max J H Witjes; Ann Hoeben; Stefan M Willems; Elisabeth Bloemena; Laura A Smit; Sjoukje F Oosting; Marianne A Jonker; Uta E Flucke; Carla M L van Herpen
Journal:  Int J Cancer       Date:  2018-03-23       Impact factor: 7.396

8.  Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.

Authors:  Khalid Hussain Al-Qahtani; Mutahir A Tunio; Yasser Bayoumi; Venkada Manickam Gurusamy; Fahad Ahmed A Bahamdain; Hanadi Fatani
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-05-16

9.  Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.

Authors:  Kuninori Otsuka; Yorihisa Imanishi; Yuichiro Tada; Daisuke Kawakita; Satoshi Kano; Kiyoaki Tsukahara; Akira Shimizu; Hiroyuki Ozawa; Kenji Okami; Akihiro Sakai; Yuichiro Sato; Yushi Ueki; Yukiko Sato; Toyoyuki Hanazawa; Hideaki Chazono; Kaoru Ogawa; Toshitaka Nagao
Journal:  Ann Surg Oncol       Date:  2016-01-20       Impact factor: 5.344

10.  Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.

Authors:  Ke He; Hu Qu; Li-Nan Xu; Jun Gao; Fu-Yi Cheng; Peng Xiang; Can-Quan Zhou
Journal:  Biosci Rep       Date:  2016-09-16       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.